Indore SEZ Exports Rise 10% in FY25–26, Pharma Sector Leads Growth

Exports from the Indore Special Economic Zone (SEZ) increased by 10% in the financial year 2025–26, driven primarily by strong performance in the pharmaceutical sector, according to recent data, highlighting the growing contribution of drug manufacturing and healthcare products to India’s export economy.

The rise in outbound shipments reflects sustained demand for pharmaceutical products in international markets, as well as increased production capacity and competitiveness among manufacturers operating within the SEZ.

Pharmaceutical Sector Drives Export Growth

The pharmaceutical industry emerged as the key contributor to export growth from the Indore SEZ during FY25–26. Companies engaged in drug manufacturing and formulation accounted for a significant share of total exports, supporting the overall 10% increase recorded during the year.

The sector’s performance underscores India’s position as a major global supplier of generic medicines and healthcare products. Export demand has remained steady due to the continued need for affordable medications, particularly in emerging and developing markets.

Manufacturers within the SEZ have benefited from established supply chains, regulatory compliance capabilities, and access to international markets, enabling them to expand their export footprint.

SEZ Ecosystem Supports Industrial Expansion

The Indore SEZ has played a critical role in facilitating export-oriented industrial activity by offering infrastructure, tax incentives, and streamlined regulatory processes. These factors have helped attract pharmaceutical companies and other export-driven industries to the region.

The SEZ framework supports efficient production and logistics operations, allowing companies to scale up manufacturing and meet international demand. In addition, proximity to transportation networks and ports has enhanced the ease of exporting goods to global markets.

The growth in exports reflects the effectiveness of such ecosystems in promoting industrial development and boosting economic output in specific sectors.

Global Demand and Healthcare Needs Sustain Momentum

The increase in pharmaceutical exports aligns with broader global healthcare trends, where demand for medicines, vaccines, and therapeutic products continues to rise. Factors such as population growth, aging demographics, and the prevalence of chronic diseases are contributing to sustained demand.

India’s pharmaceutical industry has been a key beneficiary of these trends, leveraging its cost advantages and manufacturing expertise to supply medicines worldwide. The performance of the Indore SEZ highlights how regional manufacturing hubs contribute to meeting global healthcare needs.

Export growth also reflects ongoing efforts by Indian companies to expand into regulated markets by meeting quality and compliance standards required by international authorities.

Economic and Public Health Implications

The expansion of pharmaceutical exports has implications beyond economic growth, contributing to improved access to medicines globally. Affordable drug supplies from India play a crucial role in supporting healthcare systems in various countries, particularly in low- and middle-income regions.

At the same time, increased export activity strengthens India’s domestic pharmaceutical sector by driving investment, job creation, and technological advancement. This, in turn, enhances the country’s capacity to respond to public health needs both domestically and internationally.

The performance of export-oriented pharmaceutical units also highlights the importance of maintaining quality standards and regulatory compliance to sustain trust in global markets.

Outlook for Export Growth and Industry Expansion

The 10% growth in exports from the Indore SEZ indicates continued momentum in the pharmaceutical sector, with expectations of further expansion as global demand for healthcare products remains strong. Industry stakeholders are likely to focus on scaling production, improving efficiency, and diversifying export markets.

Government policies supporting manufacturing, innovation, and export promotion are expected to play a role in sustaining this growth trajectory. In addition, investments in research and development may enhance the value of exported products, moving beyond generics to more advanced therapies.

The ongoing performance of the Indore SEZ underscores its role as a key hub in India’s pharmaceutical export landscape, contributing to both economic development and global healthcare supply chains.